Correlation Between QBE Insurance and Abcellera Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both QBE Insurance and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining QBE Insurance and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between QBE Insurance Group and Abcellera Biologics, you can compare the effects of market volatilities on QBE Insurance and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in QBE Insurance with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of QBE Insurance and Abcellera Biologics.

Diversification Opportunities for QBE Insurance and Abcellera Biologics

0.39
  Correlation Coefficient

Weak diversification

The 3 months correlation between QBE and Abcellera is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding QBE Insurance Group and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and QBE Insurance is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on QBE Insurance Group are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of QBE Insurance i.e., QBE Insurance and Abcellera Biologics go up and down completely randomly.

Pair Corralation between QBE Insurance and Abcellera Biologics

Assuming the 90 days horizon QBE Insurance is expected to generate 1.96 times less return on investment than Abcellera Biologics. But when comparing it to its historical volatility, QBE Insurance Group is 1.65 times less risky than Abcellera Biologics. It trades about 0.08 of its potential returns per unit of risk. Abcellera Biologics is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  260.00  in Abcellera Biologics on August 29, 2024 and sell it today you would earn a total of  40.00  from holding Abcellera Biologics or generate 15.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy97.67%
ValuesDaily Returns

QBE Insurance Group  vs.  Abcellera Biologics

 Performance 
       Timeline  
QBE Insurance Group 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in QBE Insurance Group are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak forward indicators, QBE Insurance may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Abcellera Biologics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite quite fragile fundamental indicators, Abcellera Biologics disclosed solid returns over the last few months and may actually be approaching a breakup point.

QBE Insurance and Abcellera Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with QBE Insurance and Abcellera Biologics

The main advantage of trading using opposite QBE Insurance and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if QBE Insurance position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.
The idea behind QBE Insurance Group and Abcellera Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance